The effects of the prolactin inhibiting drug, cabergoline, on pregnant and lactating marsupials were investigated in four species from three diverse families: the tammar wallaby, Macropus eugenii, the quokka, Setonix 
Introduction
Cabergoline is a synthetic dopamine agonist which suppresses prolactin secretion from the anterior pituitary in a number of eutherian mammals, including rats, dogs, cats, foxes and humans (Di Salle et al, 1983; Post et al, 1988; Jochle and Jochle, 1993; Onclin et al, 1993; Ferrari et al, 1995; Ferrara et al, 1995; Marks et al, 1996) . Bromocriptine has been widely used as a dopamine agonist (Vance el al, 1984) but, in clinical trials in humans, it is not as potent, long-lasting or well tolerated as the ergot derivative, cabergoline (Rolland et al, 1991; Ferrari el al, 1995) .
In humans, a single orai dose of 10 µg cabergoline kgc auses maximal inhibition of serum prolactin concentrations within hours of treatment, and the effect is sustained for at least 7 days (Pontiroli et al, 1987; Rolland et al, 1991; Ferrari et al, 1995) . Oral treatment of beagle bitches during late pregnancy with 5 µg cabergoline kg causes a decrease in prolactin to basal concentrations within 24 h, inducing premature luteolysis and abortion (Post et al, 1988) . Similarly, oral administration of 20 µg cabergoline kg~1 to red foxes, Vulpes vulpes, significantly reduces prolactin concentrations (Cowley, 1993) and causes a significant decline in cub activity, expected to be a consequence of increased abortion (Marks et al., 1996) . In lactating rats, dogs and cats, both oral and i.m. treatment with cabergoline inhibits prolactin secretion and effectively reduces or terminates milk production, thereby retarding growth of young (Jochle et al., 1989; Ferrara et al, 1995) . The effect of prolactin-inhibiting drugs during lactation in ruminant animals is less well defined. In cattle, sheep and goats, intramuscular injection of bromocriptine immediately pre partum will inhibit prolactin secretion and prevent the onset of lactation but, if administered post partum when lactation is established, milk yield remains unchanged (Hart, 1973; Smith et al, 1974) .
Nothing is known about the effects of cabergoline on reproduction in marsupials. Bromocriptine injection in the tammar wallaby, Macropus eugenii, inhibits prolactin secretion without affecting parturition, induces reactivation of the quiescent corpus luteum and diapausing blastocyst, and inhibits lactation (Tyndale-Biscoe and Hinds, 1984; Fletcher el al, 1990; Rentree et al, 1994 (Curlewis et al, 1986; Loudon and Brinklow, 1990; Hinds and TyndaleBiscoe, 1994) . As in the macropodid marsupials (Hinds and Tyndale-Biscoe, 1985; Muths and Hinds, 1996) , in the dasyurids (Hinds and Merchant, 1986) and phalangerids (Hinds and Janssens, 1986) plasma prolactin concentrations are low during early lactation, when poikilothermic young are perma¬ nently attached to the teat and milk production is low (Tyndale-Biscoe and Rentree, 1987) . Prolactin increases during late lactation, with the rapid increase in milk production and growth rate of the young (Tyndale-Biscoe and Renfree, 1987) . The effects of inhibiting prolactin during lactation on pouch young growth in these non-macropodid marsupials has not been investigated.
The importance of prolactin for reproduction in both eutherian and marsupial mammals (Cowie, 1984;  Tyndale- Biscoe and Renfree, 1987) (Poole et al, 1991) . Adult female quokkas (Setonix brachyurus) (2.6-3.7 kg) of Rottnest Island, West Australia origin, were also held in our breeding colony as described above. Pouch young were aged from pes and tail length (Shield and Woolley, 1961 (Fig. lb) (Fig. 3a) (Fig. 3b) . One young, from a female given 20 µg cabergoline kg~i .m., was found dead 2 days after treatment.
This young was not emaciated and had lost only 5% of its initial bodyweight. However, the mammary gland of the female had regressed, suggesting that the young may have died from partial failure of lactation.
Fat-tailed dunnart
Effects of intramuscular treatment during late lactation. Caber¬ goline injection (20 pg kg~x) had no significant effect on the increase in litter weight (P> 0.1) (Fig. 4) (Fletcher et al, 1990) . A prepartum surge in prolactin is essential for mammary gland development and the initiation of lactation in a number of eutherian species (Kann and Denamur, 1974; Karg and Schams, 1974 (Ferrara et al, 1995) . The high mortality of tammar neonates after cabergoline or bromocriptine treatment supports the hypothesis that a prepartum pulse of prolactin (TyndaleBiscoe et al, 1983 ) is essential for the establishment of lactation in this marsupial species (Fletcher et al, 1990; Renfree et al, 1994 (Gordon et al, 1988) , or if prolactin is suppressed for >3 days consecutively (Hinds, 1994 (Jochle et al, 1989) . Bromocriptine is also apparently inactive orally in the tammar, and Hinds and Tyndale-Biscoe (1994) suggest that this is due to inactivation of alkaloids in their ruminant-like fore stomach.
In brushtail possums, i.m. injection with 20 pg cabergoline kg~h ad no effect on pouch young growth during early or late lactation, but double this dose in late lactation transiently slowed their growth. This shows that possums are less sensitive to cabergoline treatment than are tammars and quokkas. A strong dose-related association between cabergo¬ line and lactation inhibition is evident in eutherian species, including lactating dogs (Jochle et al, 1989) and rats (Ferrara et al, 1995 
